One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v124.21.4541.4541
Copy DOI Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 43 |
Affiliation: University of Adelaide, Royal Liverpool University Hospital, Institut Bergonié, Seoul St. Mary's Hospital, Tris Pharma (United States), The University of Texas MD Anderson Cancer Center, University of Chicago, Charité - Universitätsmedizin Berlin, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Osaka City University Hospital, Sarah Cannon, Jena University Hospital, Novartis (Switzerland), University of TurinEfficacy and Safety of Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Long-Term Follow-Up (f/u) of ENESTnd
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
